Cargando…
Liraglutide Overdose-Induced Acute Pancreatitis
Liraglutide, a long-acting cardioprotective glucagon-like peptide (GLP)-1 analog, is effective for medical weight loss and glycemic control in type 2 diabetes. It is generally well tolerated with mild side effects. There are few reports on complications from Liraglutide overdose. The aim of this pap...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874232/ https://www.ncbi.nlm.nih.gov/pubmed/35228970 http://dx.doi.org/10.7759/cureus.21616 |
_version_ | 1784657638569541632 |
---|---|
author | AlSaadoun, Aljawhara R AlSaadoun, Tariq R Al Ghumlas, Abdullah K |
author_facet | AlSaadoun, Aljawhara R AlSaadoun, Tariq R Al Ghumlas, Abdullah K |
author_sort | AlSaadoun, Aljawhara R |
collection | PubMed |
description | Liraglutide, a long-acting cardioprotective glucagon-like peptide (GLP)-1 analog, is effective for medical weight loss and glycemic control in type 2 diabetes. It is generally well tolerated with mild side effects. There are few reports on complications from Liraglutide overdose. The aim of this paper is to report the case of a 25-year-old healthy female who presented with acute pancreatitis secondary to Liraglutide overdose and to review the current literature on Liraglutide used for obesity management. The current literature examining the association between acute pancreatitis and Liraglutide use, and Liraglutide overdose are inconclusive. Further research is recommended. |
format | Online Article Text |
id | pubmed-8874232 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-88742322022-02-27 Liraglutide Overdose-Induced Acute Pancreatitis AlSaadoun, Aljawhara R AlSaadoun, Tariq R Al Ghumlas, Abdullah K Cureus Emergency Medicine Liraglutide, a long-acting cardioprotective glucagon-like peptide (GLP)-1 analog, is effective for medical weight loss and glycemic control in type 2 diabetes. It is generally well tolerated with mild side effects. There are few reports on complications from Liraglutide overdose. The aim of this paper is to report the case of a 25-year-old healthy female who presented with acute pancreatitis secondary to Liraglutide overdose and to review the current literature on Liraglutide used for obesity management. The current literature examining the association between acute pancreatitis and Liraglutide use, and Liraglutide overdose are inconclusive. Further research is recommended. Cureus 2022-01-25 /pmc/articles/PMC8874232/ /pubmed/35228970 http://dx.doi.org/10.7759/cureus.21616 Text en Copyright © 2022, AlSaadoun et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Emergency Medicine AlSaadoun, Aljawhara R AlSaadoun, Tariq R Al Ghumlas, Abdullah K Liraglutide Overdose-Induced Acute Pancreatitis |
title | Liraglutide Overdose-Induced Acute Pancreatitis |
title_full | Liraglutide Overdose-Induced Acute Pancreatitis |
title_fullStr | Liraglutide Overdose-Induced Acute Pancreatitis |
title_full_unstemmed | Liraglutide Overdose-Induced Acute Pancreatitis |
title_short | Liraglutide Overdose-Induced Acute Pancreatitis |
title_sort | liraglutide overdose-induced acute pancreatitis |
topic | Emergency Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874232/ https://www.ncbi.nlm.nih.gov/pubmed/35228970 http://dx.doi.org/10.7759/cureus.21616 |
work_keys_str_mv | AT alsaadounaljawharar liraglutideoverdoseinducedacutepancreatitis AT alsaadountariqr liraglutideoverdoseinducedacutepancreatitis AT alghumlasabdullahk liraglutideoverdoseinducedacutepancreatitis |